Same Indication

Panitumumab vs Sitagliptin

Panitumumab vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Panitumumab and Sitagliptin.

Mechanism of Action

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Sitagliptin — 12.4 hours.

Chemical Properties

Molecular Formula: Sitagliptin — C16H15F6N5O.

Molecular Weight: Sitagliptin — 407.3140 g/mol.

Type: Panitumumab — Antibody; Sitagliptin — Small molecule.